DRZID
VIVO

DePrince Race & Zollo Inc (DRZ)’s Meridian Bioscience Inc VIVO Stock Holding History

DePrince Race & Zollo Inc (DRZ)’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-498,102
Closed -$11.8M – 328
2013
Q3 		$11.8M Sell
498,102
-709,767
-59% -$16.6M 0.16% 160
2013
Q2 		$26M Buy
+1,207,869
New +$26M 0.35% 110

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

DePrince Race & Zollo Inc (DRZ)'s VIVO Position: Q4 2013 in Review

DePrince Race & Zollo Inc (DRZ) sold out of Meridian Bioscience Inc (VIVO) in Q4 2013, closing a stake of 498,102 shares — an estimated $11.8M sold.

DePrince Race & Zollo Inc (DRZ) first reported a position in VIVO in Q2 2013 and held it in 2 quarters. The position peaked at $26M in Q2 2013. 170 funds tracked by Wall St. Rank hold VIVO as of Q4 2013.

  • DePrince Race & Zollo Inc (DRZ) reported no remaining Meridian Bioscience Inc position as of Q4 2013 after selling out during the quarter.
  • DePrince Race & Zollo Inc (DRZ) sold 498,102 Meridian Bioscience Inc shares in Q4 2013, an estimated $11.8M.
  • DePrince Race & Zollo Inc (DRZ) first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 2 quarters.
  • DePrince Race & Zollo Inc (DRZ)'s Meridian Bioscience Inc position peaked at $26M in Q2 2013.
  • 170 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2013.

Based on DePrince Race & Zollo Inc (DRZ)'s 13F filing for Q4 2013, filed 11 Feb 2014.